SCO­TUS to re­view Am­gen-Sanofi patent bat­tle as a proxy for how nar­row­ly phar­ma patents will need to be writ­ten

The Supreme Court has agreed to take up a long-run­ning patent bat­tle be­tween PC­SK9 fron­trun­ners Am­gen and Sanofi that has spilled in­to a broad­er is­sue …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA